Follow
Philip Barter
Philip Barter
Univrsity of New South Wales Australia
Verified email at unsw.edu.au
Title
Cited by
Cited by
Year
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on …
RA Nishimura, CM Otto, RO Bonow, BA Carabello, JP Erwin III, ...
Circulation 129 (23), e521-e643, 2014
9314*2014
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
JC LaRosa, SM Grundy, DD Waters, C Shear, P Barter, JC Fruchart, ...
New England Journal of Medicine 352 (14), 1425-1435, 2005
48972005
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
CT Trialists
The Lancet 376 (9753), 1670-1681, 2010
4230*2010
Effects of torcetrapib in patients at high risk for coronary events
PJ Barter, M Caulfield, M Eriksson, SM Grundy, JJP Kastelein, M Komajda, ...
New England journal of medicine 357 (21), 2109-2122, 2007
36762007
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
A Keech, RJ Simes, P Barter, J Best, R Scott, MR Taskinen, P Forder, ...
Lancet (London, England) 366 (9500), 1849-1861, 2005
35412005
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
J Dupuis, C Langenberg, I Prokopenko, R Saxena, N Soranzo, ...
Nature genetics 42 (2), 105-116, 2010
24982010
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
New England Journal of Medicine 339 (19), 1349-1357, 1998
24711998
Effects of dalcetrapib in patients with a recent acute coronary syndrome
GG Schwartz, AG Olsson, M Abt, CM Ballantyne, PJ Barter, J Brumm, ...
New England Journal of Medicine 367 (22), 2089-2099, 2012
22482012
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)
PH Jones, MH Davidson, EA Stein, HE Bays, JM McKenney, E Miller, ...
The American journal of cardiology 92 (2), 152-160, 2003
21722003
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
P Barter, AM Gotto, JC LaRosa, J Maroni, M Szarek, SM Grundy, ...
New England journal of medicine 357 (13), 1301-1310, 2007
21212007
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ...
Jama 305 (24), 2556-2564, 2011
18582011
Antiinflammatory properties of HDL
PJ Barter, S Nicholls, KA Rye, GM Anantharamaiah, M Navab, ...
Circulation research 95 (8), 764-772, 2004
16832004
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity
R Ross, IJ Neeland, S Yamashita, I Shai, J Seidell, P Magni, RD Santos, ...
Nature Reviews Endocrinology 16 (3), 177-189, 2020
11702020
Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis
PJ Barter, HB Brewer Jr, MJ Chapman, CH Hennekens, DJ Rader, ...
Arteriosclerosis, thrombosis, and vascular biology 23 (2), 160-167, 2003
11062003
Effect of two intensive statin regimens on progression of coronary disease
SJ Nicholls, CM Ballantyne, PJ Barter, MJ Chapman, RM Erbel, P Libby, ...
New England Journal of Medicine 365 (22), 2078-2087, 2011
10982011
High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules
GW Cockerill, KA Rye, JR Gamble, MA Vadas, PJ Barter
Arteriosclerosis, thrombosis, and vascular biology 15 (11), 1987-1994, 1995
10851995
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs
ND Yeomans, Z Tulassay, L Juhász, I Rácz, JM Howard, ...
New England Journal of Medicine 338 (11), 719-726, 1998
10531998
International Day for the Evaluation of Abdominal Obesity (IDEA) a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168 000 primary care patients …
B Balkau, JE Deanfield, JP Després, JP Bassand, KAA Fox, SC Smith Jr, ...
Circulation 116 (17), 1942-1951, 2007
10262007
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
FIELD Study Investigators
The Lancet 366 (9500), 1849-1861, 2005
851*2005
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
IJ Neeland, R Ross, JP Després, Y Matsuzawa, S Yamashita, I Shai, ...
The lancet Diabetes & endocrinology 7 (9), 715-725, 2019
8252019
The system can't perform the operation now. Try again later.
Articles 1–20